IVIEW Therapeutics Inc.

Quick facts

Marketed products

• NATACYN® · Other

Phase 2 pipeline

• IVIEW-1201
• IVW-1001 Ophthalmic Eyelid Wipe
• IVW-1001 Ophthalmic Eyelid Wipe 0.2%
• IVW-1001 Ophthalmic Eyelid Wipe 0.4%

Phase 1 pipeline

• GVB-2001-high dose
• GVB-2001-low dose
• IVW-1001 Ophthalmic Eyelid Wipe 0.1%

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• IVIEW Therapeutics Inc. portfolio CI brief
• IVIEW Therapeutics Inc. pipeline updates RSS